Oligo or polyalkylene glycol-coupled thrombin inhibitors
CA 2431487 C · Owner: Nowak, Goetz · Inventors: Nowak, Goetz; Steinmetzer, Torsten
Overview
Its claims, description and drawings are in the Canadian Patents Database.
Open the CIPO recordAbstract From the Canadian patent
The present invention relates to novel covalent oligo and polyalkylene glycol conjugates , with synthetic inhibitors of trypsin-type serine proteases in particular , inhibitors of the , hemocoagulation protease thrombin synthetic intermediates stages required in their , production and their use for producing active ingredients for the treatment or prophylaxis of thrombotic complications.
Read the whole patent
Listed from its CIPO record in Patent Yard's archive of Canadian patents past their term. Its claims, description and drawings are in the CIPO record and on Google Patents, and the Claude kit works from them.
Why it's free to use
- Filed January 23, 2002 and granted March 27, 2012. A Canadian patent filed from October 1, 1989 lasts 20 years from filing, so its term ended January 23, 2022.
- A certificate of supplementary protection adds at most two years for a drug, so even that would have ended by January 23, 2024.
- We check Canadian rights only. A patent in its family in another country could still be in force: check its family on Google Patents.
Timeline
Timeline From CIPO dates
Sources & verification
Official CIPO records
Everything on this page comes from the CIPO record linked above. Contains information licensed under the Open Government Licence – Canada.